JSB Market Research: PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2022
During the forecast period from 2012-2022, the growth of the ulcerative colitis market will be driven largely by the entry of Johnson & Johnsons (J&Js) Simponi and Takedas Entyvio, which will lead to an increase in the overall number of patients being treated with biologics in the US, 5EU, Japan, and Canada. See More: http://goo.gl/tW6DQL
During the forecast period from 2012-2022, the growth of the ulcerative colitis market will be driven largely by the entry of Johnson & Johnsons (J&Js) Simponi and Takedas Entyvio, which will lead to an increase in the overall number of patients being treated with biologics in the US, 5EU, Japan, and Canada.
See More: http://goo.gl/tW6DQL
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
10.3.3 Drivers <strong>and</strong> Barriers 250<br />
10.4 Germany 253<br />
10.4.1 <strong>Forecast</strong> 253<br />
10.4.2 Key Events 257<br />
10.4.3 Drivers <strong>and</strong> Barriers 257<br />
10.5 Italy 259<br />
10.5.1 <strong>Forecast</strong> 259<br />
10.5.2 Key Events 263<br />
10.5.3 Drivers <strong>and</strong> Barriers 263<br />
10.6 Spain 265<br />
10.6.1 <strong>Forecast</strong> 265<br />
10.6.2 Key Events 269<br />
10.6.3 Drivers <strong>and</strong> Barriers 269<br />
10.7 United Kingdom 271<br />
10.7.1 <strong>Forecast</strong> 271<br />
10.7.2 Key Events 275<br />
10.7.3 Drivers <strong>and</strong> Barriers 275<br />
10.8 Japan 277<br />
10.8.1 <strong>Forecast</strong> 277<br />
Email ID- contact@jsbmarketresearch.com<br />
Tel No- 91 2241236650<br />
Published by- http:/www.jsbmarketresearch.com/
Change language